Drug profile · INN
eluxadoline
TRUBERZI
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
eluxadoline (TRUBERZI) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN eluxadoline
Brand TRUBERZI
Route ORAL
Formulation TABLET
ATC code A07
Related patents
Search patents →Frequently asked questions
What is eluxadoline?
eluxadoline (TRUBERZI) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for eluxadoline?
TRUBERZI is a marketed brand name for eluxadoline. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of eluxadoline?
eluxadoline has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.